Sight Sciences Appoints Matt Link as Chief Commercial Officer
Sight Sciences announced the appointment of Matthew Link as its Chief Commercial Officer, effective September 11, 2023.
Mr. Link has more than 20 years of experience building teams and leading innovation in the health care and medical technology industries, most recently serving as Managing Partner at Orion Healthcare Advisors LLC, a consulting services provider. Before Orion, Mr. Link spent nearly 15 years in regional and executive leadership positions at NuVasive, a provider of surgical implants that enable technology for spine surgery and orthopedics, where he designed and executed strategies that supported the company’s revenue growth from less than $100 million to over $1 billion. Mr. Link joined NuVasive as an Area Business Manager and rose to the level of President, where his responsibilities included oversight of global business units in spine, neurophysiology, and orthopedics.
“We are very excited to have Matt join Sight Sciences as we scale our surgical glaucoma and dry eye businesses. Matt is a highly talented medtech business leader with a track record of success in transforming treatment paradigms with disruptive new technology, and predictably scaling in a public high-growth medtech setting," Paul Badawi, Founder and Chief Executive Officer of Sight Sciences, said in a company news releaes. "We believe his market development experience with procedurally focused, less invasive solutions utilizing disruptive technology that transformed spine surgery positions him well to accelerate the procedural transformation of glaucoma and dry eye disease treatment with our interventional OMNI Surgical System and TearCare System technologies."
“I am delighted to be joining Sight Sciences at this critical juncture as the glaucoma and dry eye categories are undergoing significant transformation," Mr. Link said. "Sight Sciences is a leader in eyecare technology innovation with a portfolio and pipeline of products that are elevating the standard of care. I am ready to leverage my strong commercial strategy and development background in high-growth medtech to help Sight Sciences achieve its fullest potential. I look forward to working with Paul and the Sight Sciences team to improve the lives of our patients and help the company achieve its growth and profitability objectives.”